Related Experiment Video

Updated: Jun 24, 2026

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Molecular characterization of STAT signaling in inflammation and tumorigenesis

Alicja Adach1, Aleksandra Ellert-Miklaszewska, Bozena Kaminska

  • 1Laboratory of Transcription Regulation, Nencki Institute, Warsaw, Poland.

Methods in Molecular Biology (Clifton, N.J.)
|April 7, 2009
PubMed

Insights

The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is active in many tumors, regulating cell growth and immune cell interactions. Researchers can measure STAT activation and modulate this pathway using specific antibodies and DNA decoys.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway is frequently activated in various tumor types.
  • This pathway plays a crucial role in regulating cell proliferation, differentiation, survival, and intercellular communication, particularly between cancer and immune cells.

Purpose of the Study:

  • To investigate the activation mechanisms and regulatory roles of the JAK-STAT pathway in cancer.
  • To explore methods for measuring STAT protein activation and modulating STAT-dependent gene expression.

Main Methods:

  • Utilizing commercially available antibodies to detect phosphorylated (active) STAT proteins in cell extracts.
  • Employing reporter gene assays in transfected cells to measure STAT-dependent transcriptional activity.
  • Using oligodeoxynucleotide (ODN) STAT decoys to specifically inhibit the JAK-STAT signaling pathway.

Main Results:

  • Antibodies can effectively distinguish between total and phosphorylated STAT forms, enabling direct measurement of STAT activation.
  • Reporter assays allow for the assessment of nuclear translocation and transcriptional activity of STATs.
  • STAT decoy ODNs provide a specific means to modulate STAT signaling and downstream gene expression.

Conclusions:

  • The JAK-STAT pathway is a significant target in cancer due to its role in tumor growth and immune modulation.
  • Specific antibodies and reporter gene assays are valuable tools for studying STAT activation and function.
  • STAT decoy ODNs offer a promising strategy for therapeutic intervention by inhibiting aberrant JAK-STAT signaling in cancer.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...